» Articles » PMID: 22012619

The Cyclin K/Cdk12 Complex Maintains Genomic Stability Via Regulation of Expression of DNA Damage Response Genes

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2011 Oct 21
PMID 22012619
Citations 254
Authors
Affiliations
Soon will be listed here.
Abstract

Various cyclin-dependent kinase (Cdk) complexes have been implicated in the regulation of transcription. In this study, we identified a 70-kDa Cyclin K (CycK) that binds Cdk12 and Cdk13 to form two different complexes (CycK/Cdk12 or CycK/Cdk13) in human cells. The CycK/Cdk12 complex regulates phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II and expression of a small subset of human genes, as revealed in expression microarrays. Depletion of CycK/Cdk12 results in decreased expression of predominantly long genes with high numbers of exons. The most prominent group of down-regulated genes are the DNA damage response genes, including the critical regulators of genomic stability: BRCA1 (breast and ovarian cancer type 1 susceptibility protein 1), ATR (ataxia telangiectasia and Rad3-related), FANCI, and FANCD2. We show that CycK/Cdk12, rather than CycK/Cdk13, is necessary for their expression. Nuclear run-on assays and chromatin immunoprecipitations with RNA polymerase II on the BRCA1 and FANCI genes suggest a transcriptional defect in the absence of CycK/Cdk12. Consistent with these findings, cells without CycK/Cdk12 induce spontaneous DNA damage and are sensitive to a variety of DNA damage agents. We conclude that through regulation of expression of DNA damage response genes, CycK/Cdk12 protects cells from genomic instability. The essential role of CycK for organisms in vivo is further supported by the result that genetic inactivation of CycK in mice causes early embryonic lethality.

Citing Articles

Telomemore enables single-cell analysis of cell cycle and chromatin condensation.

Yakovenko I, Mihai I, Selinger M, Rosenbaum W, Dernstedt A, Groning R Nucleic Acids Res. 2025; 53(3).

PMID: 39878215 PMC: 11775621. DOI: 10.1093/nar/gkaf031.


Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.

PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.


CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer.

Park J, Kim J Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770431 PMC: 11676443. DOI: 10.3390/ph17121589.


CDK12 antagonizes a viral suppressor of RNAi to modulate antiviral RNAi in .

Zhang L, Liang Y, Qin J, Liu C, Shang M, Sun X mBio. 2024; 16(1):e0286824.

PMID: 39601580 PMC: 11708023. DOI: 10.1128/mbio.02868-24.


A non-canonical role of somatic Cyclin D/CYD-1 in oogenesis and in maintenance of reproductive fidelity, dependent on the FOXO/DAF-16 activation state.

Rautela U, Sarkar G, Chaudhary A, Chatterjee D, Rosh M, Arimbasseri A PLoS Genet. 2024; 20(11):e1011453.

PMID: 39546504 PMC: 11602045. DOI: 10.1371/journal.pgen.1011453.


References
1.
De Siervi A, De Luca P, Byun J, DI L, Fufa T, Haggerty C . Transcriptional autoregulation by BRCA1. Cancer Res. 2010; 70(2):532-42. PMC: 2952428. DOI: 10.1158/0008-5472.CAN-09-1477. View

2.
Qiu H, Hu C, Hinnebusch A . Phosphorylation of the Pol II CTD by KIN28 enhances BUR1/BUR2 recruitment and Ser2 CTD phosphorylation near promoters. Mol Cell. 2009; 33(6):752-62. PMC: 2683426. DOI: 10.1016/j.molcel.2009.02.018. View

3.
Krutzik P, Trejo A, Schulz K, Nolan G . Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. Methods Mol Biol. 2010; 699:179-202. DOI: 10.1007/978-1-61737-950-5_9. View

4.
Lin S, Coutinho-Mansfield G, Wang D, Pandit S, Fu X . The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol. 2008; 15(8):819-26. PMC: 2574591. DOI: 10.1038/nsmb.1461. View

5.
Phatnani H, Greenleaf A . Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006; 20(21):2922-36. DOI: 10.1101/gad.1477006. View